Your browser doesn't support javascript.
loading
Seroprevalence of herpes simplex virus type 1 and type 2 among the migrant workers in Qatar.
Nasrallah, Gheyath K; Dargham, Soha R; Al-Sadeq, Duaa W; Amanullah, Fathima H; Shurrab, Farah M; Nizamuddin, Parveen B; Chemaitelly, Hiam; Ayoub, Houssein H; Abdeen, Sami; Abdelkarim, Ashraf; Daraan, Faisal; Ismail, Ahmed; Mostafa, Nahid; Sahl, Mohamed; Suliman, Jinan; Tayar, Elias; Kasem, Hasan Ali; Agsalog, Meynard J A; Akkarathodiyil, Bassam K; Alkhalaf, Ayat A; Alakshar, Mohamed Morhaf M H; Al-Qahtani, Abdulsalam Ali A H; Al-Shedifat, Monther H A; Ansari, Anas; Ataalla, Ahmad Ali; Chougule, Sandeep; Gopinathan, Abhilash K K V; Poolakundan, Feroz J; Ranbhise, Sanjay U; Saefan, Saed M A; Thaivalappil, Mohamed M; Thoyalil, Abubacker S; Umar, Inayath M; Al Kuwari, Einas; Coyle, Peter; Jeremijenko, Andrew; Kaleeckal, Anvar Hassan; Abdul Rahim, Hanan F; Yassine, Hadi M; Al Thani, Asmaa A; Chaghoury, Odette; Al Kuwari, Mohamed Ghaith; Farag, Elmoubasher; Bertollini, Roberto; Al Romaihi, Hamad Eid; Al Khal, Abdullatif; Al-Thani, Mohamed H; Abu-Raddad, Laith J.
Afiliação
  • Nasrallah GK; Biomedical Research Center, Qatar University, Doha, Qatar. gheyath.nasrallah@qu.edu.qa.
  • Dargham SR; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, 2713, Doha, Qatar. gheyath.nasrallah@qu.edu.qa.
  • Al-Sadeq DW; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Amanullah FH; World Health Organization Collaborating Centre for Disease Epidemiology Analytics On HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar.
  • Shurrab FM; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Nizamuddin PB; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Chemaitelly H; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, 2713, Doha, Qatar.
  • Ayoub HH; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Abdeen S; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, 2713, Doha, Qatar.
  • Abdelkarim A; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Daraan F; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, 2713, Doha, Qatar.
  • Ismail A; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
  • Mostafa N; World Health Organization Collaborating Centre for Disease Epidemiology Analytics On HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar.
  • Sahl M; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Suliman J; Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences, Qatar University, Doha, Qatar.
  • Tayar E; Hamad Medical Corporation, Doha, Qatar.
  • Kasem HA; Hamad Medical Corporation, Doha, Qatar.
  • Agsalog MJA; Ministry of Public Health, Doha, Qatar.
  • Akkarathodiyil BK; Ministry of Public Health, Doha, Qatar.
  • Alkhalaf AA; Ministry of Public Health, Doha, Qatar.
  • Alakshar MMMH; Hamad Medical Corporation, Doha, Qatar.
  • Al-Qahtani AAAH; Ministry of Public Health, Doha, Qatar.
  • Al-Shedifat MHA; Hamad Medical Corporation, Doha, Qatar.
  • Ansari A; Hamad Medical Corporation, Doha, Qatar.
  • Ataalla AA; Qatar Red Crescent Society, Doha, Qatar.
  • Chougule S; Qatar Red Crescent Society, Doha, Qatar.
  • Gopinathan AKKV; Qatar Red Crescent Society, Doha, Qatar.
  • Poolakundan FJ; Qatar Red Crescent Society, Doha, Qatar.
  • Ranbhise SU; Qatar Red Crescent Society, Doha, Qatar.
  • Saefan SMA; Qatar Red Crescent Society, Doha, Qatar.
  • Thaivalappil MM; Qatar Red Crescent Society, Doha, Qatar.
  • Thoyalil AS; Qatar Red Crescent Society, Doha, Qatar.
  • Umar IM; Qatar Red Crescent Society, Doha, Qatar.
  • Al Kuwari E; Qatar Red Crescent Society, Doha, Qatar.
  • Coyle P; Qatar Red Crescent Society, Doha, Qatar.
  • Jeremijenko A; Qatar Red Crescent Society, Doha, Qatar.
  • Kaleeckal AH; Qatar Red Crescent Society, Doha, Qatar.
  • Abdul Rahim HF; Qatar Red Crescent Society, Doha, Qatar.
  • Yassine HM; Qatar Red Crescent Society, Doha, Qatar.
  • Al Thani AA; Qatar Red Crescent Society, Doha, Qatar.
  • Chaghoury O; Qatar Red Crescent Society, Doha, Qatar.
  • Al Kuwari MG; Hamad Medical Corporation, Doha, Qatar.
  • Farag E; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Bertollini R; Hamad Medical Corporation, Doha, Qatar.
  • Al Romaihi HE; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, UK.
  • Al Khal A; Hamad Medical Corporation, Doha, Qatar.
  • Al-Thani MH; Hamad Medical Corporation, Doha, Qatar.
  • Abu-Raddad LJ; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Virol J ; 20(1): 188, 2023 08 22.
Article em En | MEDLINE | ID: mdl-37608372
ABSTRACT

BACKGROUND:

Limited data exists on herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) infections in migrant populations. This study investigated HSV-1 and HSV-2 seroprevalences and associations among craft and manual workers (CMWs) in Qatar who constitute 60% of Qatar's population.

METHODS:

A national population-based cross-sectional seroprevalence survey was conducted on the CMW population, all men, between July 26 and September 9, 2020. 2,612 sera were tested for anti-HSV-1 IgG antibodies using HerpeSelect 1 ELISA IgG kits and for anti-HSV-2 IgG antibodies using HerpeSelect 2 ELISA IgG kits (Focus Diagnostics, USA). Univariable and multivariable logistic regression analyses were conducted to identify associations with HSV-1 and HSV-2 infections.

RESULTS:

Serological testing identified 2,171 sera as positive, 403 as negative, and 38 as equivocal for HSV-1 antibodies, and 300 sera as positive, 2,250 as negative, and 62 as equivocal for HSV-2 antibodies. HSV-1 and HSV-2 seroprevalences among CMWs were estimated at 84.2% (95% CI 82.8-85.6%) and 11.4% (95% CI 10.1-12.6%), respectively. HSV-1 infection was associated with nationality, educational attainment, and occupation. HSV-2 infection was associated with age, nationality, and educational attainment.

CONCLUSIONS:

Over 80% of CMWs are infected with HSV-1 and over 10% are infected with HSV-2. The findings highlight the need for sexual health programs to tackle sexually transmitted infections among the CMW population.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Migrantes / Herpesvirus Humano 1 / Herpes Simples Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male País/Região como assunto: Asia Idioma: En Revista: Virol J Assunto da revista: VIROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Qatar

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Migrantes / Herpesvirus Humano 1 / Herpes Simples Tipo de estudo: Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male País/Região como assunto: Asia Idioma: En Revista: Virol J Assunto da revista: VIROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Qatar